Novartis AG (NYSE:NVS) went down by -0.58% from its latest closing price compared to the recent 1-year high of $99.84. The company’s stock price has collected -0.21% of loss in the last five trading sessions. The Wall Street Journal reported on 01/12/21 that Twitter, Tesla, Realty Income: What to Watch When the Stock Market Opens Today
Is It Worth Investing in Novartis AG (NYSE :NVS) Right Now?
Novartis AG (NYSE:NVS) scored a price-to-earnings ratio above its average ratio, recording 30.22 x from its present earnings ratio. Plus, the 36-month beta value for NVS is at 0.59. Opinions of the stock are interesting as 15 analysts out of 25 who provided ratings for Novartis AG declared the stock was a “buy,” while 2 rated the stock as “overweight,” 6 rated it as “hold,” and 2 as “sell.”
The average price from analysts is $107.61, which is $13.69 above the current price. NVS currently public float of 2.27B and currently shorts hold a 0.19% ratio of that float. Today, the average trading volume of NVS was 1.88M shares.
NVS’s Market Performance
NVS stocks went down by -0.21% for the week, with a monthly jump of 0.74% and a quarterly performance of 6.73%, while its annual performance rate touched -1.13%. The volatility ratio for the week stands at 0.96% while the volatility levels for the past 30 days are set at 1.08% for Novartis AG. The simple moving average for the period of the last 20 days is 1.45% for NVS stocks with a simple moving average of 7.27% for the last 200 days.
NVS Trading at 4.64% from the 50-Day Moving Average
After a stumble in the market that brought NVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.54% of loss for the given period.
Volatility was left at 1.08%, however, over the last 30 days, the volatility rate increased by 0.96%, as shares surge +3.05% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +19.51% upper at present.
During the last 5 trading sessions, NVS fell by -0.21%, which changed the moving average for the period of 200-days by +13.93% in comparison to the 20-day moving average, which settled at $92.11. In addition, Novartis AG saw -1.19% in overturn over a single year, with a tendency to cut further losses.
Reports are indicating that there were more than several insider trading activities at NVS starting from Novartis Bioventures Ltd, who purchase 125,000 shares at the price of $17.00 back on Jun 30. After this action, Novartis Bioventures Ltd now owns 1,181,258 shares of Novartis AG, valued at $2,125,000 using the latest closing price.
Stock Fundamentals for NVS
Current profitability levels for the company are sitting at:
- +21.25 for the present operating margin
- +69.63 for the gross margin
The net margin for Novartis AG stands at +15.04. The total capital return value is set at 10.49, while invested capital returns managed to touch 8.12. Equity return is now at value 13.20, with 5.70 for asset returns.
Based on Novartis AG (NVS), the company’s capital structure generated 52.54 points at debt to equity in total, while total debt to capital is 34.44. Total debt to assets is 24.62, with long-term debt to equity ratio resting at 39.76. Finally, the long-term debt to capital ratio is 26.06.
When we switch over and look at the enterprise to sales, we see a ratio of 4.88, with the company’s debt to enterprise value settled at 0.12. The receivables turnover for the company is 5.13 and the total asset turnover is 0.37. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.04.